Euretos, (www.euretos.com) founded in 2012 in the Netherlands, provides an AI platform mainly used by pre & early-clinical researchers for in-silico discovery & validation of targets and biomarkers. The platform enables a systems biology approach where researchers discover how x-omics molecular mechanisms influence cell and tissue functions, and in turn mediate phenotypes and disease pathology. By integrating over 200 different public databases, the platform provides the largest single environment in which the latest multi-omics data is interlinked to literature, experimental and clinical evidence. Euretos gives the power of AI and ‘big data’ analytics in the hands of the researcher via an intuitive search engine, easy to use analytics functions and embedded workflows tailored for specific research questions. The data integrated into the platform include genetic, genomic and proteomic annotations, expression profiles, experimental and animal models, diseases, phenotypes, pathways, small molecules - covering metabolites, food ingredients, as well as therapeutic agents (antibodies and peptides). Company proprietary data can be integrated into the platform for even more optimal results and hosted in a secure cloud environment or installed on-site.